Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

Ambulatory heart rate and target organ damage in never-treated essential hypertensives

Abstract

Limited evidence is available about the relationship between ambulatory heart rate (HR) and target organ damage (TOD) in uncomplicated hypertension. We sought to investigate the association between ambulatory HR and subclinical cardiac, vascular and renal markers of TOD in never-treated essential hypertensives. A total of 580 subjects with recently diagnosed (1 year) grade 1 and 2 hypertension, categorized by tertiles of HR levels, assessed by two 24-h ambulatory blood pressure monitoring at 1- to 4-week interval, sex and the presence or absence of TOD were considered for this analysis. All subjects also underwent laboratory and ultrasonographic investigations searching for microalbuminuria (MA), left ventricular hypertrophy (LVH) and carotid atherosclerosis (carotid thickening/plaque). In the whole population, as well as in both genders, LVH, carotid atherosclerosis and MA prevalence rates did not significantly increase with 48-h HR tertiles. When patients were categorized according to the presence or absence of TOD (that is, LVH, carotid atherosclerosis or MA) no significant intergroup differences in 48-h HR were found. Furthermore, average 48-h HR was similar in patients without organ involvement as in those with one, two or three TOD signs. Finally, in a multivariate analysis age, 48-h systolic blood pressure and metabolic syndrome assessed by ATP III criteria, but not HR were independently associated with TOD. Our findings showing that 48-h ambulatory HR is not associated with markers of TOD do not support the view that a faster HR may have an additive value in predicting organ damage in the early phases of essential hypertension.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1

Similar content being viewed by others

References

  1. Levy RL, White PD, Stroud WD, Hillman CC . Transient tachycardia: prognostic significance alone and in association with transient hypertension. JAMA 1945; 129: 585–588.

    Article  Google Scholar 

  2. Palatini P, Julius S . Heart rate and the cardiovascular risk. J Hypertens 1997; 15: 3–17.

    Article  CAS  Google Scholar 

  3. Palatini P, Benetos A, Grassi G, Julius S, Kjeldsen SE, Mancia G et al. Identification and management of the hypertensive patient with elevated heart rate: statement of a European Society Hypertension Consensus Meeting. J Hypertens 2006; 24: 603–610.

    Article  CAS  Google Scholar 

  4. Erikssen J, Rodahl K . Resting heart rate in apparently healthy middle-aged men. Eur J Appl Physiol 1979; 42: 61–69.

    Article  CAS  Google Scholar 

  5. Nakiewicz K, Somers VK . Interactive effect of heart rate and muscle sympathetic nerve activity on blood pressure. Circulation 1999; 100: 2514–2518.

    Article  Google Scholar 

  6. Gillmann MW, Kannel WB, Belanger A, D'Agostino RB . Influence of heart rate on mortality among persons with hypertension: the Framingham study. Am Heart J 1993; 125: 1148–1154.

    Article  Google Scholar 

  7. Benetos A, Rudnichi A, Thomas F, Safar M, Guize L . Influence of heart rate on mortality in a French population: role of age, gender and blood pressure. Hypertension 1999; 33: 44–52.

    Article  CAS  Google Scholar 

  8. Thomas F, Rudnichi A, Bacri AM, Bean K, Guize L, Benetos A . Cardiovascular mortality in hypertensive men according to presence of associated risk factors. Hypertension 2001; 37: 1256–1261.

    Article  CAS  Google Scholar 

  9. Palatini PL, Thijs L, Staessen JA, Fagard RH, Bulpitt CJ, Clement D et al. Predictive value of clinic and ambulatory heart rate for mortality in elderly subjects with systolic hypertension. Arch Intern Med 2002; 162: 2313–2321.

    Article  Google Scholar 

  10. Sa Cunha R, Pannier B, Benetos A, Sichè JP, London GM, Mallion JM et al. Association between high heart rate and high arterial rigidity in normotensive and hypertensive subjects. J Hypertens 1997; 15: 1423–1430.

    Article  CAS  Google Scholar 

  11. Heidland UE, Strauer BE . Left ventricular muscle mass and elevated heart rate are associated with coronary plaque disruption. Circulation 2001; 104: 1477–1482.

    Article  CAS  Google Scholar 

  12. Zakopoulos NA, Ikonomidis I, Vemmos KN, Manios E, Spiliopoulou I, Tisivgoulis G et al. Twenty-four-hour heart rate and blood pressure are additive markers of left ventricular mass in hypertensive subjects. Am J Hypertens 2006; 19: 170–177.

    Article  Google Scholar 

  13. Williams B, Poulter NR, Brown MJ, Gordon MD, McInnes GT, Potter JF et al. British Hypertension Society guidelines for hypertension management 2004 (BHS-IV): summary. BMJ 2004; 328: 634–640.

    Article  Google Scholar 

  14. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL et al. The seventh report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure. The JNC 7 Report. JAMA 2003; 289: 2560–2572.

    Article  CAS  Google Scholar 

  15. Guidelines Committee. 2003 European Society of Hypertension—European Society of Cardiology guidelines for the Management of Arterial Hypertension. J Hypertens 2003; 21: 1011–1053.

    Article  Google Scholar 

  16. World Health Organization, International Society of Hypertension Writing Group. 2003 World Health Organization (WHO)/International Society of Hypertension (ISH) Statement on Management of Hypertension. J Hypertens 2003; 21: 1983–1992.

    Article  Google Scholar 

  17. Cuspidi C, Meani S, Fusi V, Valerio C, Catini E, Sala C et al. Prevalence and correlates of left atrial enlargement in essential hypertension: role of ventricular geometry and the metabolic syndrome. The Evaluation of target Organ Damage in Hypertension study. J Hypertens 2005; 23: 875–882.

    Article  CAS  Google Scholar 

  18. Devereux RB, Reickek N . Echocardiographic determination of left ventricular mass in man. Anatomic validation of the method. Circulation 1977; 55: 613–618.

    Article  CAS  Google Scholar 

  19. Ganau A, Devereux RB, Roman MJ, de Simone G, Pickering TG, Saba TG et al. Patterns of left ventricular geometry and geometric remodelling in essential hypertension. J Am Coll Cardiol 1992; 19: 1550–1558.

    Article  CAS  Google Scholar 

  20. Pignoli P, Tremoli E, Poli A, Paoletti R . Intimal plus media thickness of the arterial wall: a direct measurement with ultrasound imaging. Circulation 1986; 74: 1399–1408.

    Article  CAS  Google Scholar 

  21. de Simone G, Devereux RB, Daniels SR, Koren MJ, Meyer RA, Laragh JH . Effect of growth on variability of left ventricular mass; assessment of allometric signals in adults and children and their capacity to predict cardiovascular risk. J Am Coll Cardiol 1995; 25: 1056–1062.

    Article  CAS  Google Scholar 

  22. Cuspidi C, Lonati L, Macca G, Sampieri L, Fusi V, Michev I et al. Prevalence of left ventricular hypertrophy and carotid thickening in a large selected population: impact of different echocardiographic and ultrasonographic diagnostic criteria. Blood Press 2001; 10: 142–149.

    Article  CAS  Google Scholar 

  23. Armario P, del Rey RH, Sanchez P, Martin-Baranera M, Torres G, Julia J et al. Determinants of left ventricular mass in untreated mildly hypertensive subjects: hospitalet study in mild hypertension. Am J Hypertens 1999; 12: 1084–1090.

    Article  CAS  Google Scholar 

  24. Berenson GS, Vooks AW, Webber LS, Dalferes Jr ER, Harsha DW . Racial differences of parameters associated with blood pressure levels in children. The Bogalusa Heart Study. Metabolism 1979; 28: 2218–2228.

    Article  Google Scholar 

  25. Palatini P, Winnicki M, Santonastaso M, De Venuto G, Zanata G, Bertolo O et al. Reproducibility of heart rate measured in the clinic and with 24-h intermittent recorders. Am J Hypertens 2000; 13: 92–98.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Corresponding author

Correspondence to C Cuspidi.

Additional information

Conflict of interest

None.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Cuspidi, C., Valerio, C., Meani, S. et al. Ambulatory heart rate and target organ damage in never-treated essential hypertensives. J Hum Hypertens 22, 89–95 (2008). https://doi.org/10.1038/sj.jhh.1002281

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.jhh.1002281

Keywords

This article is cited by

Search

Quick links